Muscular Dystrophy Association Announces Seven Recipient Organizations of Advocacy Collaboration Grants
01 févr. 2024 08h46 HE
|
Muscular Dystrophy Association
New York, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Today, the Muscular Dystrophy Association (MDA) announced $140,000 in funding from its MDA Advocacy Collaboration Grant Program, awarding the following...
Muscular Dystrophy Association Announces Recipient of 2024 MDA Legacy Award for Achievement in Research, is Jeffrey Chamberlain, Ph.D., Leading Professor in Gene Therapy
30 janv. 2024 09h59 HE
|
Muscular Dystrophy Association
New York, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced Jeffrey Chamberlain, Ph.D., a leading professor in gene therapy focused on Duchenne muscular...
Muscular Dystrophy Association Opens Registration for Campers and Volunteers for MDA Summer Camp 2024 to be Held at Locations Nationwide
22 janv. 2024 09h00 HE
|
Muscular Dystrophy Association
New York, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) announced today the opening of registration for both campers and volunteers for its MDA Summer Camp program. MDA...
Muscular Dystrophy Association Announces 2024 National Ambassador Ira Walker
08 janv. 2024 09h00 HE
|
Muscular Dystrophy Association
New York, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) has selected 39-year-old Ira Walker from Fort Lauderdale, Florida, as its 2024 MDA National Ambassador. Walker...
Muscular Dystrophy Association Announces Acosta Group’s Historic $100 Million Fundraising Milestone
21 déc. 2023 09h00 HE
|
Muscular Dystrophy Association
New York, Dec. 21, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) announced today that long-term partner Acosta Group has reached a historic $100 million milestone in fundraising...
Muscular Dystrophy Association Launches Holiday Retail Campaign in Thousands of Retail Locations Nationwide
01 nov. 2023 09h00 HE
|
Muscular Dystrophy Association
New York, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today launched its largest Holiday Retail Campaign to fundraise in thousands of retail locations nationwide from...
Muscular Dystrophy Association Announces Collaboration with Mitsubishi Tanabe Pharma America for Remote Digital Technology Research Study for Amyotrophic Lateral Sclerosis (ALS)
30 oct. 2023 09h01 HE
|
Muscular Dystrophy Association
New York, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Muscular Dystrophy Association (MDA) and Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced their collaboration for a remote observational...
Muscular Dystrophy Association-Supported Drug AGAMREE® (vamorolone) Approved for the Treatment of Duchenne Muscular Dystrophy by the FDA
26 oct. 2023 16h24 HE
|
Muscular Dystrophy Association
New York, Oct. 26, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) celebrates the US Food and Drug Administration (FDA) approval of AGAMREE® (vamorolone), a structurally unique...
Muscular Dystrophy Association Celebrates FDA Approval of ZILBRYSQ® zilucoplan for the Treatment of Generalized Myasthenia Gravis (gMG) in Adult Patients
18 oct. 2023 14h36 HE
|
Muscular Dystrophy Association
New York, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) celebrates the US Food and Drug Administration (FDA) approval of ZILBRYSQ® zilucoplan for the treatment of...
Muscular Dystrophy Association Celebrates FDA Approval of Amicus Therapeutics’ Pombiliti + Opfolda for Treatment of Pompe Disease
28 sept. 2023 17h00 HE
|
Muscular Dystrophy Association
New York, Sept. 28, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) celebrates the US Food and Drug Administration (FDA) approval of Pombiliti™ (cipaglucosidase alfa-atga) +...